Interferon neutralizing antibodies in multiple sclerosis: a new perspective.
Phillips
J Theodore
JT
D057134:Antibodies, Neutralizing / Q000097:blood*; D002490:Central Nervous System / Q000187:drug effects / Q000276:immunology / Q000503:physiopathology; D002986:Clinical Trials as Topic / Q000592:standards; D004351:Drug Resistance / Q000276:immunology; D006801:Humans; D007049:Iatrogenic Disease / Q000517:prevention & control; D007107:Immune System / Q000187:drug effects / Q000502:physiology; D016899:Interferon-beta / Q000009:adverse effects* / Q000276:immunology*; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000276:immunology* / Q000503:physiopathology; D055502:Secondary Prevention
D057134:Antibodies, Neutralizing; D016899:Interferon-beta